FeesSafety
Pluang+

Rigel reports Q3 2026 revenues of $80.9M, launches VEPPANU with $6.6M sales, and advances cancer drug R289.

Company Fundamentals
05 Nov 2026, 23:01 WIB
PRNewsWire
View Source
Bullish
Rigel reports Q3 2026 revenues of $80.9M, launches VEPPANU with $6.6M sales, and advances cancer drug R289.

Rigel Pharmaceuticals reported $80.9 million in total revenues for Q3 2026, including $72.3 million from product sales and $8.6 million from collaborations. The company launched VEPPANU in August, generating $6.6 million in initial sales, marking a significant milestone as the first FDA-approved PROTAC for certain breast cancers. Rigel is also progressing its Phase 1b study of R289 for lower-risk myelodysplastic syndrome, with updated data expected in December. The company updated its 2026 revenue outlook to $290-$295 million and expects to remain profitable while investing in clinical development.

Rigel Pharmaceuticals' Q3 2026 financial results provide context for health-sector market activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 06, 2026 02:12 WIB: out of 150 priced US health-sector stocks, 12 rose and 138 fell. Notable movers include BFLY at USD 5.95 with a 1-day change of -12.11% and a typical hold time on Pluang of 10 days, SMMT at USD 14.29 with a -11.63% change and balanced order activity, and ALMS at USD 5.79 with a -11.60% change and a typical hold time of 22 days.

More News

TransMedics raises 2026 revenue guidance after Q3 revenue jumps 41% with strong growth and new FDA trial approvals

TransMedics raises 2026 revenue guidance after Q3 revenue jumps 41% with strong growth and new FDA trial approvals

TransMedics Group reported a 41% revenue increase to $203 million in Q3 2026, driven by growth in organ transplant products and services. The company raised its full-year 2026 revenue guidance to $764-$774 million, including contributions from its ne...

Company Fundamentals
Bullish
5 hours ago
Axon invests $1.2B to become exclusive Skydio drone distributor for US and Canada public safety.

Axon invests $1.2B to become exclusive Skydio drone distributor for US and Canada public safety.

Axon announced a $1.2 billion investment in Skydio, increasing its ownership stake by about 20% at a $5.2 billion valuation. This deal makes Axon the exclusive distributor of Skydio drones for public safety agencies in the U.S. and Canada, expanding ...

Market News
Bullish
5 hours ago
Wynn Resorts Q3 2026 revenue drops to $1.69B with net income falling to $17.3M amid market challenges.

Wynn Resorts Q3 2026 revenue drops to $1.69B with net income falling to $17.3M amid market challenges.

Wynn Resorts reported a decline in Q3 2026 operating revenues to $1.69 billion from $1.83 billion in Q3 2025, with net income dropping sharply to $17.3 million from $88.3 million year-over-year. The decrease was driven by lower revenues across its Ma...

Company Fundamentals
Bearish
5 hours ago
Ross Stores to announce Q3 2026 earnings on Nov 19 with live webcast available.

Ross Stores to announce Q3 2026 earnings on Nov 19 with live webcast available.

Ross Stores, Inc. will release its third quarter 2026 earnings on November 19, 2026, at 4:00 p.m. Eastern time. Investors can listen to a live webcast of the conference call starting at 4:15 p.m. on the company's website. Ross Stores operates nearly ...

Company Fundamentals
Neutral
5 hours ago
Scout Clean Energy's 183 MW Nimbus Wind Farm in Arkansas starts commercial operations, powering 40,000 homes.

Scout Clean Energy's 183 MW Nimbus Wind Farm in Arkansas starts commercial operations, powering 40,000 homes.

Scout Clean Energy has announced that its 183 MW Nimbus Wind Farm in Carroll County, Arkansas, is now commercially operational after two years of construction. The wind farm, the largest in Arkansas, generates enough electricity to power over 40,000 ...

Market News
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App